Hopital Sacre-Coeur
- UEI
- V4N8DWJGYM95
- CAGE
- SHUC7
- Primary NAICS
- 622110 General Medical and Surgical Hospitals
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- Other NAICS codes in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Catholic Medical Mission Board Haiti | NU2GGH002384 | $37,500 | |
| Catholic Medical Mission Board Haiti | NU2GGH002384 | $156,000 | |
| Catholic Medical Mission Board Haiti | NU2GGH002384 | $390,000 | |
| University Of Miami | R01HL149121 | $37,961 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Charess | Port-au-Prince, Ouest | — |
| MOH Building And Strengthening Haiti's National Plan For PRE | Port-au-Prince, Ouest | — |
| Hope Cote D'ivoire | Abidjan, District Autonome d'Abidjan | 624190 Other Individual and Family Services |
| Zanmi Lasante | Croix-des-Bouquets, Ouest Department | 923120 Administration of Public Health Programs |
| Horwath Central America, S. De R.l. De C.V. | Francisco Morazán Department | 541611 Administrative Management and General Management Consulting Services |
About the company
Hopital Sacre-Coeur, a not-for-profit hospital in Haiti, operates exclusively as a federal grant sub-recipient, delivering HIV/AIDS treatment and clinical research services under awards from the Centers for Disease Control and Prevention and the National Institutes of Health.
The hospital holds three federal grant sub-awards totaling $584 thousand, all awarded between March 2024 and October 2025. Two awards flow through Catholic Medical Mission Board Haiti as the prime grantee: a sub-award dated October 2024 supporting HIV counseling, testing, and prevention of mother-to-child transmission services under the ALESIDA2 project, targeting 95% enrollment of HIV-positive patients on antiretroviral therapy and viral suppression outcomes; and a follow-on sub-award dated October 2025 continuing the same clinical objectives. The third sub-award, dated March 2024 and prime-awarded to the University of Miami, positions Sacre-Coeur Hospital as a participating clinical research site in a comparative study of sickle cell disease across North Haitian and Miami cohorts of Haitian-American and Haitian immigrant children, with Dr. Michele Hanna serving as center investigator. That study spans a five-year period and includes newborn screening at the hospital's maternity ward, prospective cohort follow-up, and coordination with partner sites in Port-au-Prince.
Hopital Sacre-Coeur has no federal prime contracts, no seat on government-wide vehicles, and no subcontractor roles on federal contracts — its federal footprint is entirely grant sub-recipient work. Activity consists of two CDC awards and one NIH/NHLBI award, with no recompete signals visible in the current source window. The hospital operates as a clinical delivery and research-site partner rather than a contracting vendor, serving international health and disease-surveillance missions for U.S. federal health agencies.
Quick answers
Is Hopital Sacre-Coeur registered in SAM.gov?
Hopital Sacre-Coeur's SAM.gov registration expired on December 12, 2025.
On GovTribe
See Hopital Sacre-Coeur's full federal record
- Similar vendors